Clinical Trial Search

Primary: Physical Activity Hours Per Day Measured Using a Body-worn Accelerometer at Baseline — 1.3; 1.6 h/day — p=0.037

Primary: Craving Change in Stress and Cue Relative to Neutral — 3.035; -0.486; 3.959; 0.031 score on a scale — p=<.001

Primary: Change in Dark Adaptation Rod Intercept Time (RIT) From Baseline in the Study Eye at the Treatment Completion Visit (Month 2 for Cohort 1 and Month 1 for Cohort 2)…

Primary: Subjective Rewarding Value of Cigarillo Flavoring — 4.03; 3.63; 3.30 score on a scale

Primary: Inflammatory Blood-Based Biomarkers — 5 fold change — p=0.05

Primary: Rate (%) of 30-day Hospital Re-admission — 3; 2; 7 Participants

Primary: Coagulopathy Associated With COVID-19 — -313; -129.5 ng/mL FEU

Primary: Comparison of Blood Lactate Levels During a 24 Minute Graded Standard Exercise Test (50 Watts, 100 Watts, and 150 Watts) to Placebo. — 0.9699; 1.1437; 1.26345; 1.3618…

Primary: Number of Patients With Dose-limiting Toxicities (DLTs) — 3 Participants

Primary: Change in Frequency of Sleep-related Eating Episodes (Time Frame: Comparing Final Study Visit to Baseline) — -41.2; -20.0 change in % of nights eating per week

Primary: Number of Participants With Cesarean Delivery — 27; 37 Participants

Primary: Pain Felt During the Procedure — 0.29; 0.30 score on a scale

Primary: Alpha Learning Rate — .62; .43; .55; .21 Alpha Coefficient

Primary: Acceptability: Satisfaction With Weekly Intervention Sessions — 13; 12; 0; 12 Participants

Primary: Rate of Treatment Related Serious Complication — 0 percentage of participants